EMBL Australia

Subscribe
  • Twitter
  • Facebook
  • LinkedIn
  • Our Research
  • Training
    • PhD Course
      • Past Courses
    • Postdoc Opportunities
    • ECR Network (formally EAPS)
      • Past Symposiums
    • Visiting EMBL
  • Infrastructure
    • Access to EMBL’s Scientific Services
    • NCRIS Health Group
  • About Us
    • What is EMBL Australia?
    • About EMBL
    • Governance
      • EMBL Australia Council
    • Partner Laboratory Network
    • Our People
    • Gender Equity Action Plan
    • Work With Us
  • News
  • Events
  • Contact
  • All News
  • News
  • Newsletters
  • Annual Reports
  • Global research infrastructure community reunites at ICRI

    News / 10 December 2024

    EMBL Australia Council Chair Emeritus Professor Ian Smith, Scientific Head Professor James Whisstock and Chief Operating Officer Annette Wittmann joined more than 400 global research infrastructure (RI) experts at the 2024 International Conference on Research Infrastructures (ICRI) in Brisbane (Meanjin). 

    Read More
  • Three group leaders awarded four ARC Discovery Project grants

    News / 28 November 2024

    Professor Eduardo Eyras, Associate Professor Robert Weatheritt and Professor Chen Davidovich have been awarded four Discovery Project grants, totalling more than $3 million.

    Read More
  • EMBL Australia invites expressions of interest for Scientific Head role

    News / 19 November 2024

    Professor James Whisstock is stepping down after eight transformative years as Scientific Head of EMBL Australia. Prof. Whisstock is a structural biologist at Monash Biomedicine Discovery Institute and Deputy Dean…
    Read More
  • Dr William Roman wins Metcalf Prize for growing human muscles on a chip

    News / 7 November 2024

    EMBL Australia group leader Dr William Roman has been awarded a 2024 Metcalf Prize for Stem Cell Research for his work growing human muscles on a chip. This technology will advance disease modelling, drug screening, cellular agriculture & biorobotics.

    Read More
  • EMBL Australia joins NCRIS Health Group to enhance collaborative health research

    News / 28 October 2024

    EMBL Australia is proud to be working together with Bioplatforms Australia, National Imaging Facility, Phenomics Australia, Population Health Research Network and Therapeutic Innovation Australia to keep Australians healthy through research innovation.

    Read More
  • EMBL Australia Scientific Head elected as new AAHMS Fellow

    News / 25 October 2024

    EMBL Australia Scientific Head Professor James Whisstock was one of the 31 newly elected Fellows of the Australian Academy of Health and Medical Sciences (AAHMS) for 2024 for his outstanding contributions to immunology.

    Read More
  • Dr Qi Zhang awarded $1.25m CSL Centenary Fellowship

    News / 24 October 2024

    EMBL Australia group leader Dr Qi Zhang has been awarded a prestigious fellowship to advance her epigenetics research, with the aim of generating fundamental knowledge to enable new cancer drugs.

    Read More
  • EMBL Australia Newsletter - September 2024

    Newsletters / 30 September 2024

    News this quarter:

    • $4m MRFF grant for RNA Mass Spectrometry Platform
    • EMBL-EBI Director Ewan Birney on ‘mind-blowing potential’ of AI
    • Dr Vaishnavi Ananthanarayanan receives Life Sciences Award
    • Future Fellowship to advance food technology, synthetic biology and agriculture
    • More funding to new therapies for untreatable muscle disorders
    • Shape the next generation of science infrastructure leaders
    • Promotions to Professors for Chen Davidovich and Edwina McGlinn
    • Get to know… Yann Gambin

    And more:

    • Job opportunities
    • Training at EMBL
    • Upcoming events
    • Recent publications
    View Newsletter
  • Ewan Birney on the ‘mind-blowing potential’ of Artificial Intelligence

    News / 17 September 2024

    Artificial intelligence (AI) and its transformative role in life sciences took centre stage at an event featuring EMBL-EBI Director Prof Ewan Birney and jointly hosted by EMBL Australia and Bioplatforms Australia.

    Read More
  • $500K top-up for biotech developing therapeutics for untreatable muscle disorders

    News / 13 September 2024

    Pioneering biotech company Myostellar, led by EMBL Australia leadership team members Professor Peter Currie and Associate Professor Mikaël Martino, has received a $500,000 top-up from CUREator to continue developing new therapies for debilitating muscular dystrophies.

    Read More
Previous 1 2 3 4 5 … 27 Next
  • Staff intranet
  • Our Research
  • Training Opportunities
    • Visiting EMBL
    • PhD Course
    • Postgraduate Symposium (EAPS)
    • Postdoc Opportunities
  • Infrastructure
    • Access to EMBL’s Scientific Services
    • NCRIS Health Group
  • About Us
    • About EMBL Australia
    • About EMBL
    • Governance
    • Partner Laboratory Network
    • Gender Equity Action Plan
    • Our People
    • Work With Us
  • News
    • News
    • Newsletters
    • Annual Reports
  • Events
  • Contact Us
    • LinkedIn
    • Twitter
    • Facebook

Participating institutions

This project is supported by
the Australian Government.

  • Privacy and Terms of Use
Back to top
Close

Subscribe to the EMBL Australia Newsletter

Keep up to date with all the latest EMBL Australia news and events.